Bausch Health Companies Inc.

DB:BVF Stock Report

Market Cap: €2.9b

Bausch Health Companies Management

Management criteria checks 2/4

Bausch Health Companies' CEO is Tom Appio, appointed in May 2022, has a tenure of 2.67 years. total yearly compensation is $15.88M, comprised of 7.4% salary and 92.6% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth €3.39M. The average tenure of the management team and the board of directors is 2.7 years and 8.5 years respectively.

Key information

Tom Appio

Chief executive officer

US$15.9m

Total compensation

CEO salary percentage7.4%
CEO tenure2.7yrs
CEO ownership0.1%
Management average tenure2.7yrs
Board average tenure8.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Tom Appio's remuneration changed compared to Bausch Health Companies's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$178m

Jun 30 2024n/an/a

-US$471m

Mar 31 2024n/an/a

-US$455m

Dec 31 2023US$16mUS$1m

-US$592m

Sep 30 2023n/an/a

-US$963m

Jun 30 2023n/an/a

-US$186m

Mar 31 2023n/an/a

-US$357m

Dec 31 2022US$13mUS$1m

-US$225m

Sep 30 2022n/an/a

US$254m

Jun 30 2022n/an/a

US$43m

Mar 31 2022n/an/a

-US$407m

Dec 31 2021US$10mUS$854k

-US$948m

Sep 30 2021n/an/a

-US$1b

Jun 30 2021n/an/a

-US$1b

Mar 31 2021n/an/a

-US$1b

Dec 31 2020US$4mUS$775k

-US$560m

Sep 30 2020n/an/a

-US$2b

Jun 30 2020n/an/a

-US$2b

Mar 31 2020n/an/a

-US$2b

Dec 31 2019US$4mUS$769k

-US$2b

Sep 30 2019n/an/a

-US$616m

Jun 30 2019n/an/a

-US$917m

Mar 31 2019n/an/a

-US$2b

Dec 31 2018US$4mUS$730k

-US$4b

Compensation vs Market: Tom's total compensation ($USD15.88M) is above average for companies of similar size in the German market ($USD1.91M).

Compensation vs Earnings: Tom's compensation has increased whilst the company is unprofitable.

CEO

Tom Appio (62 yo)

2.7yrs

Tenure

US$15,878,578

Compensation

Mr. Thomas J. Appio, also known as Tom, serves as the Chief Executive Officer & Director at Bausch Health Companies Inc. and served as Chief Executive Officer of Pharma Business and served as President & C...

Leadership Team

NamePositionTenureCompensationOwnership
Thomas Appio
CEO & Director2.7yrsUS$15.88m0.12%
€ 3.4m
Seana Carson
Executive VP & General Counsel2.7yrsUS$3.16m0.030%
€ 870.2k
Jean-Jacques Charhon
Executive VP & CFOless than a yearno datano data
Mirza Dautbegovic
Executive VP & COO3yrsno data0.036%
€ 1.0m
Garen Sarafian
VP & Head of Investor Relationsno datano datano data
Kathleen Fitzpatrick
Executive VP and Chief HR & Communications Officer3yrsno datano data
Cees Heiman
Senior Vice President of Europe & Canada3yrsno datano data
Donald Pearl
Senior Vice President of Ortho Dermatologicsno datano datano data
Jiny Kim
Senior Vice President of Solta Medical2yrsno datano data
Aimee Lenar
Executive Vice President of US Pharmaless than a yearno datano data
Jonathan Sadeh
Executive VPless than a yearno datano data
William Woodfield
Senior VP & Treasurerno datano datano data

2.7yrs

Average Tenure

55yo

Average Age

Experienced Management: BVF's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Thomas Appio
CEO & Director2.7yrsUS$15.88m0.12%
€ 3.4m
John Paulson
Independent Chairman2.6yrsUS$812.50k0.000060%
€ 1.7k
Robert Power
Independent Director16.4yrsUS$389.55k0.0018%
€ 51.2k
H. Fibiger
Chairman of External Advisory Boardno dataUS$2.00mno data
Sarah Kavanagh
Independent Director8.5yrsUS$718.28k0%
€ 0
Robert Lenox
Member of the External Advisory Board15.8yrsno datano data
Kathleen Clarence-Smith
Member of the External Advisory Board15.8yrsno datano data
Karoly Nikolich
Member of the External Advisory Board15.8yrsno datano data
Brett Icahn
Independent Director3.8yrsUS$691.72k0.00020%
€ 5.7k
Amy Wechsler
Independent Director8.6yrsUS$377.50k0.011%
€ 327.9k
Steven Miller
Independent Director3.8yrsUS$381.31k0.031%
€ 878.2k
Christian Garcia
Independent Directorless than a yearno datano data

8.5yrs

Average Tenure

67yo

Average Age

Experienced Board: BVF's board of directors are considered experienced (8.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/01 04:09
End of Day Share Price 2024/12/11 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bausch Health Companies Inc. is covered by 45 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raghuram SelvarajuAegis Capital Corporation
Douglas TsaoBarclays
Ardalan ArfaeiBMO Capital Markets Equity Research